*Can the volume predict the acute reactions ?

Slides:



Advertisements
Similar presentations
RapidArc in Bergen Britt Nygaard, Harald Valen and Ellen Wasbø
Advertisements

Advanced Practice in Radiotherapy
IMRT vs. BRACHYTHERAPY FOR SOFT TISSUE SARCOMA. EXTERNAL RT IN STS NCI Trial (Yang JC et al, JCO 1998) Extremity / Superficial Trunk STS (n=141) LSS Alone.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Evaluating a Nomogram for the Development of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated with 3D and Intensity Modulated.
Data Mining to Aid Beam Angle Selection for IMRT Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil- American University.
INTRODUCTION  The majority of clinical trials addressing outcomes in limited- stage small cell lung cancer (LS-SCLC) following definitive chemoradiotherapy.
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
Predictive models validated by clinical data: new strategies for fractionation Dr. M. Benassi Dr. S. Marzi.
A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.
Factors Influencing the Dose to Rectum During the Treatment of Prostate Cancer with IMRT Nandanuri M.S. Reddy, PhD, Brij M. Sood, MD, and Dattatreyudu.
Phase II Trial of Continuous Course Re- irradiation Concurrent with Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of The Head.
CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use Of Angiotensin- Converting Enzyme Inhibitors In Patients Receiving Lung Stereotactic.
Prostate Support Group Dr Duncan McLaren Consultant Oncologist.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
Comparison of SIB-IMRT and Conventional Accelerated Hyper-fractionated IMRT With Concurrent Cisplatin and Etoposide for Limited Disease SCLC Baosheng Li.
A Tumour Control Probability based approach to the development of Plan Acceptance Criteria for Planning Target Volume in Intensity Modulated Radiation.
3. Results (continued) Of single fraction regimens, 87% prescribed ≥16 Gy. Single fraction treatments were constrained by maximum spinal cord doses of.
Principal Author, MD Second Author, MD PhD Third Author, MSc Institution, City, Country 23 January 2013.
High Dose Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian 1, Vivian Weinberg 3, Joycelyn.
Purpose and Objectives: To investigate
Outcomes of Stereotactic Ablative Radiotherapy (SABR) for a Second Primary Lung Cancer (SPLC): Evidence in Support of Routine CT Surveillance C. J.A. Haasbeek,
Tumor Location Correlates with Radiation Pneumonitis after Stereotactic Body Radiation Therapy (SBRT) for Primary and Oligometastatic Lesions of the Lung.
Optimization of Volumetric Modulated Arc Therapy (VMAT) Planning Strategy Using Ring-shaped ROI for Localized Prostate cancer Kentaro Ishii, Masako Hosono,
Taipei VGH Practice Guidelines: Oncology Guidelines Index Cancer of Oral Cavity Version Table of Content StagingStaging, Manuscript Taipei Veterans.
Palliative Single 8 Gy Radiotherapy for Symptomatic Aggressive Lymphomas 2666 A -408 Oguchi M, Eba J, Tanaka O, Kozuka T, Murofushi K, Toshiyasu T, Tsurugai.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Stereotactic Body Radiation Therapy for Early Stage Prostate Cancer: Outcomes from a Single Institution Study Stereotactic Body Radiation Therapy for Early.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
PHASE II TRIAL OF HYPOFRACTIONATED BREAST IRRADIATION WITH VMAT-SIB TECHNIQUE: TOXICITY AND EARLY CLINICAL ASSESSMENT IN 270 PATIENTS F. De Rose¹, F. Alongi¹,
Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,
Proton Therapy Patterns-of-Care and Early Outcomes for Hodgkin Lymphoma: Results from the Proton Collaborative Group Registry Bradford Hoppe MD, MPH William.
Taipei Veterans General Hospital Practices Guidelines Oncology Rectal Cancer Version
Taipei Veterans General Hospital Practices Guidelines Oncology Oral Cavity Cancer Version
Dose Calculations for Cyberknife Stereotactic Body Radiation Therapy For CK, one can fractionate the therapy yet remain convenient and non-invasive for.
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Localized Prostate Cancer David M. Spellberg M.D., FACS.
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Locally Recurrent Head and Neck Cancer (Salvage IMRT - Dose, fractionation, volumes) Eddy S. Yang, MD, PhD Professor and Vice Chair of Translational Sciences.
Radiation therapy for Early Stage Prostate Cancer
Mitchell Hickman Head and Neck Specialist Radiographer
Principles of Radiation Oncology in (advanced stage) NSCLC
Hypofractionated radiotherapy for breast cancer
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
IMRT delivery of preoperative, high dose radiotherapy to a large volume, with Simultaneous Integrated Boost (SIB) in retroperitoneal sarcomas: The Ottawa.
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity- modulated radiation therapy and volumetric modulated arc therapy.
Improving Ear Pain of Patients with Whole Brian Radiation Therapy
Evaluation of biologically equivalent dose escalation, clinical outcome, and toxicity in prostate cancer radiotherapy: A meta-analysis of 12,000 patients.
CONTACT Catalina A. Riley
Insert tables Insert figure
Insert tables Insert graphs Insert figure
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Insert tables Insert graphs Insert figure
European Urology Oncology
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer  Christina K. Speirs, MD, PhD, Todd.
Safety of differential radiation dosing in lymph node positive necks treated with IMRT  Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,
Figure 2 Nonmalignant tissue can be spared from radiation
VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure  G. Lazzari, A. Terlizzi,
Clinical and Translational Radiation Oncology
Bradford Hoppe MD, MPH William Hartsell, MD
Planning techniques of proton boost
A, Changes in BRAFV600E cfDNA allele fraction from baseline after one dose of treatment for 12 patients with serial samples available, classified according.
Presentation transcript:

*Can the volume predict the acute reactions ? SLIDE 1 / 5 IMRT with Simultaneous Integrated Boost technique- popular technique in Head and neck cancer radiotherapy Also known as Dose Painting Simultaneous delivery of different dose levels ranging from 1.6 to 2.2 Gy per day to the targets based on their risk More than 1 Gy per volume is associated with differential gene expression and apoptosis - related with toxicity* 1Gy per day in 33 fractions EQ-D2 is 22Gy *Can 1 Gy per day be used as a constraint to reduce splay dosage in SIB IMRT ? *Can the volume predict the acute reactions ? *Jayashree B, Devasagayam TPA, Kesavan PC. Low dose radiobiology: mechanistic considerations. Curr Sci-BANGALORE-. 2001;80(4):515–23.

Methodology and results SLIDE 2 / 5 Methodology and results Retrospective review of plans of last 20 SIB IMRT treatments done in our institution in Head and neck cancer. 1Gy per day volume ( V1GD )created in ECLIPSE V 10.0.42 Low Dose Conformity Index (LDCI) = V1GD – PTV(in cc) / PTV THE LDCI of 20 patients mean median SD Min Max 1Gy volume 1824.5 1924.5 749.9 322 3187 PTV volume 579.2 612.5 276.4 100 1140 Index Score 2.3 2.105 .94 1.15 4.9

Red: 1Gy per day volume Blue: PTV volume SLIDE 3 / 5 LDCI as calculated for 20 patients with their treatment breaks No 1Gy volume PTV total LDCI =(1Gy-PTV)/PTV BREAK IN RT Patient 1 462 182 1.53 Patient 2 2180 672 2.24 Patient 3 1952 772 1.52 Patient 4 1569 262 4.98 Patient 5 1933 575.9 2.35 1 Patient 6 2457 1140 1.15 Patient 7 1916 762 1.51 Patient 8 2101 732 1.87 Patient 9 2014 729 1.76 Patient 10 1488 442 2.36 Patient 11 1472 478 2.07 Patient 12 3187 1056 2.01 Patient 13 2132 613 2.47 Patient 14 1764 570 2.09 Patient 15 501 190 1.63 Patient 16 1915 612 2.12 Patient 17 322 100 2.22 Patient 18 2642 735 2.59 Patient 19 2899 670 3.32 Patient 20 1584 293 4.4 Red: 1Gy per day volume Blue: PTV volume

Correlating LDCI and Toxicity 0.0073 0.012 SLIDE 4 / 5 Correlating LDCI and Toxicity Patient with Grade I or no mucositis Patient with Grade II or more mucositis 1 Gy volume PTV Index 462 182 1.53 1952 772 1.52 1916 762 1.51 1472 478 2.07 Median 1694 620 1.525 1 Gy volume PTV Index 2180 672 2.24 1569 262 4.98 1933 575.9 2.35 2457 1140 1.15 2101 732 1.87 1488 442 2.36 3187 1056 2.01 2132 613 2.47 1764 570 2.09 501 190 1.63 1915 612 2.12 322 100 2.22 2642 735 2.59 2899 670 3.32 1584 293 4.4 Median 2017 612.5 2.23 LDCI and Toxicity Correlation coefficient P-value Week 2 0.2053 0.3029 Week 3 0.2021 0.2924 Week 4 0.5120 0.0073 Week5 0.4816 0.012

LDCI predicts treatment breaks and acute toxicity SLIDE 5 / 5 Conclusion Low dose conformity index (LDCI)– can be calculated and Higher index values significantly correlated with greater treatment breaks after 4th week LDCI predicts treatment breaks and acute toxicity Prospectively , this index MAY be considered while analyzing IMRT plan to predict higher toxicities Lowering the Index (volume receiving 1 Gy) MAY decrease toxicity –requires further prospective studies LDCI may be used to compare rival IMRT plans when SIB technique is used 1. Schwartz et al – Accelerated radiotherapy with simultaneous integrated boost fractionation and IMRT for advanced head and neck cancer; Otolaryngology–Head and Neck Surgery (2007) 136, 549-555 2.Franceschini et al : Simultaneous Integrated Boost–Intensity-Modulated Radiotherapy in Head and Neck Cancer, The Laryngoscope, The American Laryngological, Rhinological and Otological Society, Inc 3. Studer et al - IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients, Radiation Oncology 2006 4.Hervé Abdi, The Kendall Rank Correlation Coefficient